Evaluation of Hepatitis B Surveillance System in Purbalingga Regency, Central Java 2023
Abstract
Background: In 2023, there was a difference in the number of newborns from HBsAg-reactive mothers who received HB0 and HBIg. Additionally, there were differences in the number of 9-12-month-old infants who underwent DDHB with HBsAg testing results. The aim of this study was to describe the hepatitis B surveillance system.Methods: This study used a cross-sectional design with a qualitative and quantitative approach. Descriptive analysis was used to compare hepatitis B surveillance with the applicable guidelines.Results: Implementation of hepatitis B surveillance according to the Guidelines for Prevention of Parent-to-Child Transmission of HIV, Syphilis, and Hepatitis B; the National Action Plan for the Prevention and Control of Hepatitis 2020-2024; and the Technical Guidelines for the Management of Hepatitis B and C Programs. Surveillance attributes included simplicity, data quality, and acceptance at 31.8%, timeliness at 90.9%, and stability at 86.4%.Conclusion: Hepatitis B surveillance in Purbalingga Regency has been conducted in accordance with the guidelines, however, there are several surveillance attributes that need improvement, namely data quality and acceptance, due to the program manager's negligence in updating the SIHEPI application.
Keywords: Evaluation, Surveillance System, Hepatitis B
References
Luqman, Sudaryo MK, Suprayogi A. Analisis Situasi Masalah Kesehatan Penyakit Menular di Provinsi Kalimantan Barat. J Epidemiol Kesehat Komunitas. 2022;7(1):357–74.
World Health Organization. Communicable and Noncommunicable Diseases, and Mental Health [Internet]. [cited 2024 Jan 9]. Available from: https://www.who.int/our-work/communicable-and-noncommunicable-diseases-and-mental-health
WHO. who.int. 2023 [cited 2024 Jan 9]. Hepatitis B. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=Hepatitis B can cause a,a mother to her baby.
Sabeena S, Ravishankar N. Horizontal Modes of Transmission of Hepatitis B Virus (HBV): A Systematic Review and Meta-Analysis. Iran J Public Health. 2022;51(10):2181–93.
PAEI. Kebijakan Surveilans Penyakit Yang Bisa Dicegah Dengan Imunisasi (PD3I). Paei [Internet]. 2021; Available from: http://siakpel.bppsdmk.kemkes.go.id:8102/akreditasi_kurikulum/modul_21123009470677950c2623df9a72627e7959f39988cb.pdf
Dinas Kesehatan Kabupaten Purbalingga. Laporan Hepatitis B Tahun 2021. Purbalingga; 2021.
Dinas Kesehatan Kabupaten Purbalingga. Laporan Hepatitis B Tahun 2022. Purbalingga; 2022.
Dinas Kesehatan Kabupaten Purbalingga. Laporan Hepatitis B Tahun 2023. Purbalingga; 2023.
Kemenkes RI. Modul Pelatihan Surveilans Epidemiologi Bagi Petugas Puskesmas. Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan RI. Petunjuk Teknis Manajemen Program Hepatitis B dan C. 2023;1–95.
Kemenkes RI. Pedoman Program Pencegahan Penularan HIV, Sifilis, dan Hepatitis B dari Ibu ke Anak. 2019.
Kemenkes. Peraturan Menteri Kesehatan Republik Indonesia Nomor 52 Tahun 2017 Tentang Eliminasi Penularan Human Immunodeficiency Virus, Sifilis, dan Hepatitis B Dari Ibu ke Anak. 2017;14(7):450. Available from: https://tel.archives-ouvertes.fr/tel-01514176
CDC. CDC. 2024 [cited 2024 Jun 2]. Hepatitis B Surveillance Guidance. Available from: https://www.cdc.gov/hepatitis/statistics/surveillanceguidance/HepatitisB.htm
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 23 Tahun 2022 Tentang Penanggulangan Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, Dan Infeksi Menular Seksual. Permenkes RI. 2022;69(555):1–53.
Kementerian Kesehatan RI. Rencana Aksi Nasional Pencegahan dan Pengendalian Hepatitis [Internet]. 2020. 2020–2024 p. Available from: https://www.globalhep.org/sites/default/files/content/action_plan_article/files/2022-05/RAN HEP 2020-2024 KDT_0.pdf
WHO. Communicable Disease Surveillance and Response Systems Guide to Planning. WHO. 2006;33.
CDC. Evaluating an NCD- Related Surveillance System. 2013;
Baker MG, Fidler DP. Global Public Health Surveillance Under New International Health Regulations. Emerg Infect Dis. 2006;12(7):1058–65.
Refbacks
- There are currently no refbacks.